Showing results (31-40 of 160) with videos related to
Sort By:
Pageof 16
Cancer|February 19, 2010
Disrupting established tumor blood vessels: an emerging therapeutic strategy for cancerMark J McKeage, Bruce C BaguleyFuture Oncology (London, England)|November 11, 2010
ASA404: a tumor vascular-disrupting agent with broad potential for cancer therapyBruce C Baguley, Mark J McKeageCurrent Topics in Medicinal Chemistry|February 7, 2003
Dual topoisomerase I/II inhibitors in cancer therapyWilliam A Denny, Bruce C BaguleyAnticancer Research|March 14, 2007
NF-kappaB-independent induction of endothelial cell apoptosis by the vascular disrupting agent DMXAASee-Tarn Woon, Sandy S C Hung, Derek C F Wu, et al.Frontiers in Oncology|November 22, 2014
Preliminary Evidence That High-Dose Vitamin C has a Vascular Disrupting Action in MiceBruce C Baguley, Qi Ding, Emma RichardsonNature Reviews. Cancer|June 2, 2005
Disrupting tumour blood vesselsGillian M Tozer, Chryso Kanthou, Bruce C BaguleyFrontiers in Oncology|May 31, 2013
The role of the hippo pathway in melanocytes and melanomaJi Eun Kim, Graeme J Finlay, Bruce C BaguleyBiochemical Pharmacology|June 5, 2003
Preclinical factors affecting the interindividual variability in the clearance of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acidShufeng Zhou, Philip Kestell, Bruce C Baguley, et al.Investigational New Drugs|August 31, 2002
5,6-dimethylxanthenone-4-acetic acid (DMXAA): a new biological response modifier for cancer therapyShufeng Zhou, Philip Kestell, Bruce C Baguley, et al.International Journal of Pharmaceutics|May 30, 2008
Pharmacokinetics and pharmacodynamics of chlorambucil delivered in parenteral emulsionSrinivas Ganta, James W Paxton, Bruce C Baguley, et al.Pageof 16